VITRAKVI 100 MG Oral Capsule

RxCUI: 2105645
RxNorm name: VITRAKVI 100 MG Oral Capsule
Display name: VITRAKVI 100 MG Oral Capsule
Full name: VITRAKVI 100 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VITRAKVI	LAROTRECTINIB	Bayer HealthCare Pharmaceuticals Inc.	0c8ca614-58b2-4aa4-83d3-0387a8f782fd	2026-05-22	Warnings, Adverse reactions	Exact identifier rxcui: 2105645
VITRAKVI	LAROTRECTINIB	Loxo Oncology, Inc.	9525f887-a055-4e33-8e92-898d42828cd1	2018-12-05	Warnings, Adverse reactions	Exact identifier rxcui: 2105645

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
0c8ca614-58b2-4aa4-83d3-0387a8f782fd	VITRAKVI 100 MG Oral Capsule [PSN] · larotrectinib 100 MG Oral Capsule [Vitrakvi] [SBD] · Vitrakvi 100 MG (as 123 MG larotrectinib sulfate) Oral Capsule [SY] · Vitrakvi 100 MG Oral Capsule [SY]	4	21	These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018	20260522
9525f887-a055-4e33-8e92-898d42828cd1	VITRAKVI 100 MG Oral Capsule [PSN] · larotrectinib 100 MG Oral Capsule [Vitrakvi] [SBD] · Vitrakvi 100 MG (as 123 MG larotrectinib sulfate) Oral Capsule [SY] · Vitrakvi 100 MG Oral Capsule [SY]	4	3	These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018	20181205